Logos Global Management LP Vista Gen Therapeutics, Inc. Transaction History

Logos Global Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.73 $880,000 - $1.73 Million	-1,000,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.14 - $2.09 $1.14 Million - $2.09 Million	-1,000,000 Reduced 50.0%	1,000,000 $1.24 Million
Q4 2021 Feb 14, 2022	BUY	$1.67 - $2.76 $3.34 Million - $5.52 Million	2,000,000 New	2,000,000 $3.9 Million

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $625M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.